These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21458210)
1. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"]. Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210 [TBL] [Abstract][Full Text] [Related]
2. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Al-Saleem T; Al-Mondhiry H Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584 [TBL] [Abstract][Full Text] [Related]
3. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303 [TBL] [Abstract][Full Text] [Related]
4. Heavy Chain Disease of the Small Bowel. Bianchi G; Sohani AR Curr Gastroenterol Rep; 2018 Jan; 20(1):3. PubMed ID: 29372346 [TBL] [Abstract][Full Text] [Related]
5. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease. Shih LY; Liaw SJ; Dunn P; Kuo TT J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727 [TBL] [Abstract][Full Text] [Related]
6. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease. Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719 [TBL] [Abstract][Full Text] [Related]
7. MALT lymphoma of the small bowel with protein-losing enteropathy. Tsukamoto A; Nakamura F; Nannya Y; Kobayashi Y; Shibahara J; Ichikawa M; Fukayama M; Koike K; Kurokawa M Int J Hematol; 2014 Feb; 99(2):198-201. PubMed ID: 24395281 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan. Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998 [TBL] [Abstract][Full Text] [Related]
9. A mucosa-associated lymphoid tissue (MALT) lymphoma of the small intestine that was difficult to diagnose endoscopically. Yoneda K; Takahashi H; Abe Y; Inamori M; Kato S; Uchiyama T; Iida H; Mawatari H; Hosono K; Endo H; Nozaki Y; Akiyama T; Fujita K; Yoneda M; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A Endoscopy; 2010; 42 Suppl 2():E175. PubMed ID: 20560120 [No Abstract] [Full Text] [Related]
10. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone. Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108 [TBL] [Abstract][Full Text] [Related]
12. [Primary immunoproliferative small intestinal disease]. Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R G E N; 1995; 49(3):238-42. PubMed ID: 8598264 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features of primary thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type]. Sun L; Shi HY; Wei LX Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):234-8. PubMed ID: 22800518 [TBL] [Abstract][Full Text] [Related]
14. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience. Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703 [TBL] [Abstract][Full Text] [Related]
15. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease. Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120 [TBL] [Abstract][Full Text] [Related]
16. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma]. Zahner J; Kirchner T; Ott G; Schneider W Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827 [TBL] [Abstract][Full Text] [Related]
17. Campylobacter coli cultured from the stools of a patient with immunoproliferative small intestinal disease. Coeuret S; de La Blanchardière A; Saguet-Rysanek V; Chèze S; Tavernier M; Arsène D; Criscuolo A; Brisse S; Vergnaud M; Verdon R; Lecuit M Clin Microbiol Infect; 2014 Sep; 20(9):908-11. PubMed ID: 24438451 [TBL] [Abstract][Full Text] [Related]
18. Treatment-Resistant Immunoproliferative Small Intestinal Disease (IPSID) Leading to Lymphoma. Ismail M; Nasir UM; Elaskandrany MA; Kapila R; Wang W Cureus; 2024 Jun; 16(6):e62302. PubMed ID: 39006573 [TBL] [Abstract][Full Text] [Related]
19. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study. Nair S; Mathan M; Ramakrishna BS; Mathan VI J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427 [TBL] [Abstract][Full Text] [Related]
20. A case of mucosa-associated lymphoid tissue lymphoma forming multiple lymphomatous polyposis in the small intestine. Hirata N; Tominaga K; Ohta K; Kadouchi K; Okazaki H; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Nakamura S; Oshitani N; Higuchi K; Arakawa T World J Gastroenterol; 2007 Mar; 13(9):1453-7. PubMed ID: 17457982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]